Scientist, Conjugation Chemistry
City TherapeuticsCambridge, MA
ProximaBoston, MAHybrid
53/100 · Fair. Based on age, reposts, pay, the company's hiring and ghost signals.
See the evidence behind this score.
Pro shows each part of the score, the reasons, the pay percentile and the listing history.
HirQ's ghost-risk estimate and company labels are automated opinions based on what we observe on employers' public job boards: how long a listing has been open, whether it was re-listed, wording in the description, and how often roles on that board close. They are not statements about an employer's intent, and a high-risk listing can still be a real opening. Figures are as of the date shown. How we measure
“We're not able to support remote or hybrid arrangements for this position”
Employer-posted ranges for Science & Research roles in MA in the last 12 months (377 postings).
This job: No pay listed
From Proxima's careers page, checked Nov 21
Proteomics Scientist
Location: This role is based in-person at our Boston lab, MA
We're not able to support remote or hybrid arrangements for this position
About Proxima
Proxima (formerly VantAI) is discovering the next generation of proximity therapeutics by making protein interactions programmable. Our platform brings together frontier AI models, a scalable data generation engine, and a partnership track record exceeding $5B in collaborations across the world’s leading biopharma and tech organizations. We’ve recently closed an oversubscribed seed round with an elite group of VCs including DCVC, NVIDIA’s NVentures, AIX, Yosemite among others.
Neo is our all-atom foundation model that combines state-of-the-art structure prediction and molecular generation in a single system. Neo enables rapid exploration of chemical and structural space for high value, previously intractable targets, and in particular unlocks small molecule proximity therapeutics like molecular glues with AI for the first time.
In parallel, we are developing an advanced structural interactomics platform (NeoLink https://www.vant.ai/neo-1#neolink) built on proprietary proteomics technology and a lab equipped with next-generation mass spectrometry instrumentation. This platform produces proteome-scale maps of protein interactions and identifies small molecules that modulate proximity. Together with Neo, it creates an integrated system capable of co-folding protein complexes while generating candidate small molecules to influence those interactions.
Proximity-based therapeutics represent one of most promising frontiers in modern drug discovery with the potential to treat previously intractable diseases and target ‘undruggable’ proteins. We’re building the tech and the team to make that happen. Come join us!
NeoLink is Neo’s bridge to the physical world: we leverage proteomics to directly assay molecular interactions at an amino-acid level of resolution, enabling a feedback loop where machine-learning models directly explore and learn from biology. As a Proteomics Scientist, you will play a critical role in building out NeoLink and advancing critical R&D workflows for data generation and internal programs.
Candidates currently completing a PhD or postdoc in an XLMS or chemical proteomics lab are welcome to apply - we're interested in talent about to graduate and looking to move into industry
Same role or field, nearby or remote, ranked by HirQ score.
City TherapeuticsCambridge, MA
Flagship Pioneering, Inc.Cambridge, MA USA
Oruka TherapeuticsMenlo Park, California, United States; Remote; Waltham, Massachusetts, United StatesHybrid
Beeline MedicinesCambridge, Massachusetts, United StatesHybrid
Flagship Pioneering, Inc.Cambridge, MA USA
Proteomics Scientist
No pay listed · HirQ 53